352 related articles for article (PubMed ID: 27811204)
1. Growth Differentiation Factor 15 Predicts All-Cause Morbidity and Mortality in Stable Coronary Heart Disease.
Hagström E; Held C; Stewart RA; Aylward PE; Budaj A; Cannon CP; Koenig W; Krug-Gourley S; Mohler ER; Steg PG; Tarka E; Östlund O; White HD; Siegbahn A; Wallentin L;
Clin Chem; 2017 Jan; 63(1):325-333. PubMed ID: 27811204
[TBL] [Abstract][Full Text] [Related]
2. Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: results from the PLATO study.
Hagström E; James SK; Bertilsson M; Becker RC; Himmelmann A; Husted S; Katus HA; Steg PG; Storey RF; Siegbahn A; Wallentin L;
Eur Heart J; 2016 Apr; 37(16):1325-33. PubMed ID: 26417057
[TBL] [Abstract][Full Text] [Related]
3. Association of Multiple Biomarkers With Risk of All-Cause and Cause-Specific Mortality After Acute Coronary Syndromes: A Secondary Analysis of the PLATO Biomarker Study.
Lindholm D; James SK; Gabrysch K; Storey RF; Himmelmann A; Cannon CP; Mahaffey KW; Steg PG; Held C; Siegbahn A; Wallentin L
JAMA Cardiol; 2018 Dec; 3(12):1160-1166. PubMed ID: 30427997
[TBL] [Abstract][Full Text] [Related]
4. Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study.
Wallentin L; Eriksson N; Olszowka M; Grammer TB; Hagström E; Held C; Kleber ME; Koenig W; März W; Stewart RAH; White HD; Åberg M; Siegbahn A
PLoS Med; 2021 Jan; 18(1):e1003513. PubMed ID: 33439866
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of long-term changes of growth differentiation factor-15 over a 27-year-period for heart failure and death due to coronary heart disease.
Fluschnik N; Ojeda F; Zeller T; Jørgensen T; Kuulasmaa K; Becher PM; Sinning C; Blankenberg S; Westermann D
PLoS One; 2018; 13(5):e0197497. PubMed ID: 29771963
[TBL] [Abstract][Full Text] [Related]
6. Growth Differentiation Factor 15, Its 12-Month Relative Change, and Risk of Cardiovascular Events and Total Mortality in Patients with Stable Coronary Heart Disease: 10-Year Follow-up of the KAROLA Study.
Dallmeier D; Brenner H; Mons U; Rottbauer W; Koenig W; Rothenbacher D
Clin Chem; 2016 Jul; 62(7):982-92. PubMed ID: 27197673
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial.
Held C; White HD; Stewart RAH; Budaj A; Cannon CP; Hochman JS; Koenig W; Siegbahn A; Steg PG; Soffer J; Weaver WD; Östlund O; Wallentin L;
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066452
[TBL] [Abstract][Full Text] [Related]
8. Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
Wallentin L; Hijazi Z; Andersson U; Alexander JH; De Caterina R; Hanna M; Horowitz JD; Hylek EM; Lopes RD; Asberg S; Granger CB; Siegbahn A;
Circulation; 2014 Nov; 130(21):1847-58. PubMed ID: 25294786
[TBL] [Abstract][Full Text] [Related]
9. The coincidence of low vitamin K status and high expression of growth differentiation factor 15 may indicate increased mortality risk in stable coronary heart disease patients.
Mayer O; Bruthans J; Seidlerová J; Karnosová P; Mateřánková M; Gelžinský J; Rychecká M; Opatrný J; Wohlfahrt P; Kučera R; Trefil L; Cífková R; Filipovský J; Vermeer C
Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):540-551. PubMed ID: 33257192
[TBL] [Abstract][Full Text] [Related]
10. Growth differentiation factor 15 and cardiovascular events in patients with stable ischemic heart disease (The Heart and Soul Study).
Schopfer DW; Ku IA; Regan M; Whooley MA
Am Heart J; 2014 Feb; 167(2):186-192.e1. PubMed ID: 24439979
[TBL] [Abstract][Full Text] [Related]
11. GDF-15 at admission predicts cardiovascular death, heart failure, and bleeding outcomes in patients with CAD.
Wang J; Zhang T; Xu F; Gao W; Chen M; Zhu H; Xu J; Yin X; Pang J; Zhang S; Wei M; Chen J; Liu Y; Yu X; Chew DP; Chen Y
ESC Heart Fail; 2023 Oct; 10(5):3123-3132. PubMed ID: 37620152
[TBL] [Abstract][Full Text] [Related]
12. Association of Fibroblast Growth Factor 23 With Recurrent Cardiovascular Events in Patients After an Acute Coronary Syndrome: A Secondary Analysis of a Randomized Clinical Trial.
Bergmark BA; Udell JA; Morrow DA; Cannon CP; Steen DL; Jarolim P; Budaj A; Hamm C; Guo J; Im K; Kuder JF; Braunwald E; Sabatine MS; O'Donoghue ML
JAMA Cardiol; 2018 Jun; 3(6):473-480. PubMed ID: 29710336
[TBL] [Abstract][Full Text] [Related]
13. Growth-differentiation factor-15 for risk stratification in patients with stable and unstable coronary heart disease: results from the AtheroGene study.
Kempf T; Sinning JM; Quint A; Bickel C; Sinning C; Wild PS; Schnabel R; Lubos E; Rupprecht HJ; Münzel T; Drexler H; Blankenberg S; Wollert KC
Circ Cardiovasc Genet; 2009 Jun; 2(3):286-92. PubMed ID: 20031597
[TBL] [Abstract][Full Text] [Related]
14. Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease.
Lindholm D; Lindbäck J; Armstrong PW; Budaj A; Cannon CP; Granger CB; Hagström E; Held C; Koenig W; Östlund O; Stewart RAH; Soffer J; White HD; de Winter RJ; Steg PG; Siegbahn A; Kleber ME; Dressel A; Grammer TB; März W; Wallentin L
J Am Coll Cardiol; 2017 Aug; 70(7):813-826. PubMed ID: 28797349
[TBL] [Abstract][Full Text] [Related]
15. Growth-differentiation factor 15 and risk of major bleeding in atrial fibrillation: Insights from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial.
Hijazi Z; Oldgren J; Andersson U; Connolly SJ; Eikelboom JW; Ezekowitz MD; Reilly PA; Yusuf S; Siegbahn A; Wallentin L
Am Heart J; 2017 Aug; 190():94-103. PubMed ID: 28760218
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of growth differentiation factor-15 in Chinese patients with heart failure: A prospective observational study.
Wang H; Chen Q; Li Y; Jing X; Yang J
Cardiol J; 2018; 25(2):245-253. PubMed ID: 28612904
[TBL] [Abstract][Full Text] [Related]
17. Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis.
Kato ET; Morrow DA; Guo J; Berg DD; Blazing MA; Bohula EA; Bonaca MP; Cannon CP; de Lemos JA; Giugliano RP; Jarolim P; Kempf T; Kristin Newby L; O'Donoghue ML; Pfeffer MA; Rifai N; Wiviott SD; Wollert KC; Braunwald E; Sabatine MS
Eur Heart J; 2023 Jan; 44(4):293-300. PubMed ID: 36303404
[TBL] [Abstract][Full Text] [Related]
18. Predictive Properties of Biomarkers GDF-15, NTproBNP, and hs-TnT for Morbidity and Mortality in Patients With Type 2 Diabetes With Nephropathy.
Bidadkosh A; Lambooy SPH; Heerspink HJ; Pena MJ; Henning RH; Buikema H; Deelman LE
Diabetes Care; 2017 Jun; 40(6):784-792. PubMed ID: 28341782
[TBL] [Abstract][Full Text] [Related]
19. Growth Differentiation Factor 15 Provides Prognostic Information Superior to Established Cardiovascular and Inflammatory Biomarkers in Unselected Patients Hospitalized With COVID-19.
Myhre PL; Prebensen C; Strand H; Røysland R; Jonassen CM; Rangberg A; Sørensen V; Søvik S; Røsjø H; Svensson M; Berdal JE; Omland T
Circulation; 2020 Dec; 142(22):2128-2137. PubMed ID: 33058695
[TBL] [Abstract][Full Text] [Related]
20. Growth Differentiation Factor-15 Predicts Death and Stroke Event in Outpatients With Cardiovascular Risk Factors: The J-HOP Study.
Negishi K; Hoshide S; Shimpo M; Kanegae H; Kario K
J Am Heart Assoc; 2021 Dec; 10(24):e022601. PubMed ID: 34889104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
